736 related articles for article (PubMed ID: 10598480)
1. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
2. Asthma therapy with agents preventing leukotriene synthesis or action.
Drazen JM
Proc Assoc Am Physicians; 1999; 111(6):547-59. PubMed ID: 10591083
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
4. [Leukotriene modifiers].
Minoguchi K; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
[TBL] [Abstract][Full Text] [Related]
5. Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis.
Banasiak NC; Meadows-Oliver M
Pediatr Nurs; 2005; 31(1):35-8. PubMed ID: 15794321
[No Abstract] [Full Text] [Related]
6. [Leukotriene modifiers in the treatment of asthma].
Alvarez J
Rev Alerg Mex; 1999; 46(3):72-7. PubMed ID: 10425884
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Steinke JW; Culp JA
Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
[TBL] [Abstract][Full Text] [Related]
8. New treatments for asthma: the role of leukotriene modifier agents.
Valacer DJ
J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene receptor antagonists and related compounds.
Wenzel SE
Can Respir J; 1999; 6(2):189-93. PubMed ID: 10322101
[TBL] [Abstract][Full Text] [Related]
10. The role of antileukotrienes in asthma management.
Tan RA
Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene modifiers. Expanded role may be on horizon.
Hayden ML
Adv Nurse Pract; 2000 Oct; 8(10):42-6. PubMed ID: 11761536
[No Abstract] [Full Text] [Related]
12. Antileukotrienes in asthma: present situation.
GarcĂa-Marcos L; Schuster A
Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
[TBL] [Abstract][Full Text] [Related]
13. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
Hoxha M; Rovati GE; Cavanillas AB
Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
[TBL] [Abstract][Full Text] [Related]
14. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
15. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
Bisgaard H
Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
[TBL] [Abstract][Full Text] [Related]
17. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene receptor antagonists.
Altinger JA
Lippincotts Prim Care Pract; 1998; 2(6):634-42. PubMed ID: 9883158
[No Abstract] [Full Text] [Related]
19. Leukotriene inhibitors in the treatment of allergy and asthma.
Scow DT; Luttermoser GK; Dickerson KS
Am Fam Physician; 2007 Jan; 75(1):65-70. PubMed ID: 17225706
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene-receptor antagonists. Role in asthma management.
D'Urzo AD; Chapman KR
Can Fam Physician; 2000 Apr; 46():872-9. PubMed ID: 10790819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]